Rabiu Bako

Dr. Rabiu Bako

Pharmaceutical and Medicinal Chemistry, Kaduna State University, Kaduna, Nigeria
orcid
I am open to research collaborations in synthetic medicinal

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2025 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
Rabiu BakoRabiu Bako
Rabiu Bako
NONatasha October
Natasha October
AIAbdullahi Yunusa Idris
Abdullahi Yunusa Idris
AHAsma’u Nasir Hamza
Asma’u Nasir Hamza
GAGbonjubola Olusesi Adeshina
Gbonjubola Olusesi Adeshina
YYYahaya Yakubu
Yahaya Yakubu
Antimicrobial resistance remains a major global public health challenge, contributing to increased mortality rate and treatment failures in an effort to address this growing challenge, the present research work focused on the synthesis and evaluation of new hydrazone scaffold and pyrazoline derivatives (coded HS6–HS10) as potential antimicrobial agents. The target compounds were synthesized via one-pot condensation reactions and characterized using FTIR, 1H, and 13C NMR techniques. Their antimicrobial activities were assessed in vitro against a panel of Gram-positive, Gram-negative bacteria, and fungal strains. However, their assessment revealed broad spectrum of antimicrobial activity, where the compounds bearing biaryl-substituted hydrazones with electron-donating or electron-withdrawing groups at para- and or meta-positions showed highest potency. However, MIC values of 12.5 mg/mL were observed against clinical isolates such as E. coli, S. typhi, and P. aeruginosa, while S. aureus, B. subtilis, and S. pneumoniae were inhibited at 12.5–25 mg/mL, while MIC values of 50 mg/mL were recorded against Aspergillus niger, indicating weak antifungal activity. The molecular docking studies conducted using target microbial enzymes such as dihydrofolate reductase (DHFR) and squalene epoxidase (SQLE) against the ligands HS7 and HS8 have strong binding affinities towards DHFR (− 9.6 and − 9.4 kcal/mol) and SQLE (− 9.8 and − 10.2 kcal/mol), respectively, outperforming standard reference drugs ciprofloxacin (− 7.4 kcal/mol) and terbinafine (− 9.8 kcal/mol). Meanwhile, the in silico ADME analysis confirmed that all compounds satisfied Lipinski’s rule of five, suggesting favourable drug-like properties. In conclusion, these findings suggest that substituted hydrazone and pyrazoline derivatives possess considerable promising scaffolds for developing better novel antimicrobial agents that are capable of combating resistant pathogens.

15 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
Rabiu BakoRabiu Bako
Rabiu Bako
AIAbdullahi Yunusa Idris
Abdullahi Yunusa Idris
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
GAGbonjubola O. Adeshina
Gbonjubola O. Adeshina
MGMusa Abdullahi Garba
Musa Abdullahi Garba
Antimicrobial chemotherapeutic failure as a result of pathogenic resistance stain is great concern across the globe, there is need to search for an effective antimicrobial agent from synthetic sources to overcome emergent of microbial resistant in clinical practice. The phenylhydrazone derivatives were scientifically found to have wide application in the field of drug discovery due to their anticancer, anti-tubercular, antibacterial, and antifungal activities. The (E)-Substituted-N-(phenylhydrazones) derivatives were obtained by a condensation reaction between substituted acetophenone and substituted phenyl hydrazine through a one-step reaction, resulting of five (5) novel compounds such as HS1 (E)-1-(1-(4-bromophenyl)ethylidene)-2-(2,4-dinitrophenyl)hydrazine), HS2(E)-1-(1-(4-bromophenyl)ethylidene)-2-(4-nitrophenyl)hydrazine), HS3(E)-1-(4-nitrophenyl)-2-(1-(3-nitrophenyl)ethylidene)hydrazine), HS4(E)-1-(2,4-dinitrophenyl)-2-(1-(3-nitrophenyl)ethylidene)hydrazine), and HS5 (E)-1-(1-(3-nitrophenyl)ethylidene)-2-phenylhydrazine) and the in-silico prediction of physicochemical properties were found within Lipinski’s rule of five and the synthesized compounds were established by structurally elucidations on the basis of FTIR, 1D and 2D NMR spectral analysis and the newly synthesized compounds were then subjected to antimicrobial assessment for an in vitro test evaluation using the inhibition zone technique, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC).

31 July 2026 in Molecular Modeling Connect
Verified
Journal Article
Open access
PDF file
ARAhmed Rufa'I
Ahmed Rufa'I
AIAbdullahi Y. Idris
Abdullahi Y. Idris
AMAliyu M. Musa
Aliyu M. Musa
HHHalimatu sadiya Hassan
Halimatu sadiya Hassan
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
IMIsah J. Muhammad
Isah J. Muhammad
Amides represent a class of organic compounds with a variety of biological potential and anticonvulsant properties.This study aimed to evaluate the pharmacokinetic properties and molecular interactions of 15 N-(substituted-1,3-benzothiazol-2-yl)benzamide derivatives with two key epilepsy-related targets, γ-aminobutyric acid aminotransferase (GABA-AT) and activated open sodium ion channel proteins, in order to assess their potential anticonvulsant activity. Crystal structures of GABA-AT (PDB ID: 1OHW) and the sodium ion channel (PDB ID: 5HVX) were obtained from the RCSB Protein Data Bank. Molecular docking was performed using AutoDock Vina following protein preparation in Chimera v1.11.2. Post-docking analysis was conducted using Chimera and Discovery Studio Visualizer. ADME properties were also predicted. ADME analysis showed high gastrointestinal absorption for all compounds except compound 5. Docking results revealed that seven compounds (Cp1, Cp3, Cp7, Cp10, Cp12, Cp13, and Cp14) exhibited interaction profiles similar to vigabatrin, while three (Cp10, Cp13, and Cp14) aligned with lamotrigine. These compounds demonstrated favorable binding interactions with both targets. The docking analysis suggest that selected N-(substituted-1,3-benzothiazol-2-yl)benzamide derivatives, particularly Cp1, Cp3, Cp7, Cp10, Cp12, Cp13, and Cp14 were identified as the most promising lead candidates, with significant potential for anticonvulsant activity.

13 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Rabiu BakoRabiu Bako
Rabiu Bako
IAIdris Yunusa Abdullahi
Idris Yunusa Abdullahi
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
AYAbubakar Sadiq Yakubu
Abubakar Sadiq Yakubu
NONatasha October
Natasha October
Antimicrobial chemotherapeutic failure as a result of pathogenic resistance stain is great concern across the globe, there is need to search for an effective antimicrobial agent from synthetic sources to wipe microbial resistant in clinical practice. The phenylhydrazone derivatives were scientifically found to have wide application in area of drug discovery due to their anticancer, anti-tubercular, anti-bacterial and anti-fungal activities. Five (5) novel (E)-Substituted-N-(phenylhydrazones) derivatives’ were obtained by condensation reaction through one step reaction, here are the five compounds, HS1 (E)-1-(1-(4-bromophenyl)ethylidene)-2-(2,4dinitrophenyl)hydrazine),HS2 (E)-1-(1-(4-bromophenyl)ethylidene)-2-(4-nitrophenyl)hydrazine), HS3(E)-1-(4nitrophenyl)-2-(1-(3-nitrophenyl)ethylidene)hydrazine), HS4 (E)-1-(2,4-dinitrophenyl)-2-(1-(3nitrophenyl)ethylidene)hydrazine), and HS5 (E)-1-(1-(3-nitrophenyl)ethylidene)-2-phenylhydrazine) and their structural elucidation were established on the basis of FTIR, 1D and 2D NMR spectra and the Insilco prediction of physicochemical properties found within the lipinski’s rule of five and the newly synthesized compounds were evaluated for antimicrobial assessment via an in-vitro test model using inhibition zone technique, MIC, MBC and MFC.